These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1801965)

  • 1. In vivo evaluation of the semi-simultaneous method for bioavailability estimation using controlled intravenous infusion as an 'extravascular' route of administration.
    Bredberg U; Karlsson MO
    Biopharm Drug Dispos; 1991 Nov; 12(8):583-97. PubMed ID: 1801965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of methods to calculate cyclosporine A bioavailability from consecutive oral and intravenous doses.
    Karlsson MO; Lindberg-Freijs A
    J Pharmacokinet Biopharm; 1990 Aug; 18(4):293-311. PubMed ID: 2231321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison between the semisimultaneous and the stable isotope techniques for bioavailability estimation of terbutaline in humans.
    Bredberg U; Karlsson MO; Borgström L
    Clin Pharmacol Ther; 1992 Sep; 52(3):239-48. PubMed ID: 1526079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability estimation by semisimultaneous drug administration: a Monte Carlo simulation study.
    Karlsson MO; Bredberg U
    J Pharmacokinet Biopharm; 1990 Apr; 18(2):103-20. PubMed ID: 2348378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel extravascular input function for the assessment of drug absorption in bioavailability studies.
    Weiss M
    Pharm Res; 1996 Oct; 13(10):1547-53. PubMed ID: 8899849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stepwise determination of multicompartment disposition and absorption parameters from extravascular concentration-time data. Application to mesoridazine, flurbiprofen, flunarizine, labetalol, and diazepam.
    Wagner JG; Ganes DA; Midha KK; Gonzalez-Younes I; Sackellares JC; Olson LD; Affrime MB; Patrick JE
    J Pharmacokinet Biopharm; 1991 Aug; 19(4):413-55. PubMed ID: 1920088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simultaneous oral/intravenous population pharmacokinetic model for vinorelbine.
    Variol P; Nguyen L; Tranchand B; Puozzo C
    Eur J Clin Pharmacol; 2002 Oct; 58(7):467-76. PubMed ID: 12389069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of (-)-carbovir in rats. Evidence for nonlinear elimination.
    Brouwer KR; St Claire RL; Lagarde J; Patanella JE; Walsh JS; Miwa GT
    Drug Metab Dispos; 1990; 18(6):1078-83. PubMed ID: 1981516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent intravenous administration of a labeled tracer to determine the oral bioavailability of a drug exhibiting Michaelis-Menten metabolism.
    Rubin GM; Waschek JA; Pond SM; Effeney DJ; Tozer TN
    J Pharmacokinet Biopharm; 1987 Dec; 15(6):615-31. PubMed ID: 3450845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of bioavailability on a single occasion after semisimultaneous drug administration.
    Karlsson MO; Bredberg U
    Pharm Res; 1989 Sep; 6(9):817-21. PubMed ID: 2813280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability assessment from pharmacologic data: method and clinical evaluation.
    Stagni G; Shepherd AM; Liu Y; Gillespie WR
    J Pharmacokinet Biopharm; 1997 Jun; 25(3):349-62. PubMed ID: 9474532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of amprolium in fasting and nonfasting chickens after intravenous and oral administration.
    Hamamoto K; Koike R; Machida Y
    J Vet Pharmacol Ther; 2000 Feb; 23(1):9-14. PubMed ID: 10747238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of methysergide and its metabolite methylergometrine in the rat.
    Bredberg U; Paalzow L
    Drug Metab Dispos; 1990; 18(3):338-43. PubMed ID: 1974196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of 2-chloro-2'-deoxyadenosine administered subcutaneously or by continuous intravenous infusion.
    Sonderegger T; Betticher DC; Cerny T; Lauterburg BH
    Cancer Chemother Pharmacol; 2000; 46(1):40-2. PubMed ID: 10912576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability assessment of disopyramide using pharmacokinetic-pharmacodynamic (PK-PD) modeling in the rat.
    Miyazaki M; Maekawa C; Iwanaga K; Morimoto K; Kakemi M
    Biol Pharm Bull; 2000 Nov; 23(11):1363-9. PubMed ID: 11085367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma pharmacokinetics and bioavailability of 1-(2-chloroethyl)-3-sarcosinamide-1-nitrosourea after intravenous and oral administration to mice and dogs.
    Supko JG; Garcia-Carbonero R; Puchalski TA; Malspeis L
    Cancer Chemother Pharmacol; 2001 Sep; 48(3):202-8. PubMed ID: 11592341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and bioavailability of pyrene in the rat.
    Withey JR; Law FC; Endrenyi L
    J Toxicol Environ Health; 1991 Apr; 32(4):429-47. PubMed ID: 1826747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An algorithm for constrained deconvolution based on reparameterization.
    Veng-Pedersen P; Modi NB
    J Pharm Sci; 1992 Feb; 81(2):175-80. PubMed ID: 1545358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M; Wu WH; Look ZM; Silber BM; Yacobi A
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonlinearities in amoxycillin pharmacokinetics. II. Absorption studies in the rat.
    Torres-Molina F; Peris-Ribera JE; García-Carbonell MC; Aristorena JC; Plá-Delfina JM
    Biopharm Drug Dispos; 1992 Jan; 13(1):39-53. PubMed ID: 1554876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.